Physician profile
Fares Samra
NPI 1598026148
$53,818.84
in general payments reported to CMS, 2019-2025
34 companies · $23K in 2025
The $23K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,951 · 2020: $1,081 · 2021: $2,658 · 2022: $7,276 · 2023: $8,406 · 2024: $7,711 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Honoraria: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,200 · Food and Beverage: $5,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,600.00 |
| Honoraria | $10,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,200.00 |
| Food and Beverage | $5,252.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $38,290.94 | 2022-2025 | |
| Axogen | $3,576.64 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Sientra, INC. | $3,268.88 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,595.38 | 2019-2025 | |
| Surgical Innovation Associates, INC. | $1,500.00 | 2022 | |
| Abbvie INC. | $1,172.92 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Allergan, INC. | $996.65 | 2019-2022 | |
| Motiva USA, LLC | $390.95 | 2025 | |
| Davol INC. | $342.70 | 2022-2025 | Phasix Mesh, Channel Drain |
| Mentor Worldwide LLC | $335.91 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $303.13 | 2020-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Kerecis Limited | $256.44 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $212.84 | 2020-2025 | Stravix Pl, Grafix Pl, Oasis |
| Acera Surgical, INC. | $198.77 | 2024 | Restrata Wound Matrix |
| Polynovo North America LLC | $195.46 | 2023-2025 | Novosorb Btm |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $144.44 | 2023 | Xeomin |
| Alphatec Spine, INC | $143.33 | 2024 | Invictus Mis |
| Convatec INC. | $142.98 | 2024 | |
| Acell, INC. | $125.00 | 2019 | |
| Baudax Bio INC. | $124.77 | 2022 | |
| Intuitive Surgical, INC. | $100.33 | 2023 | |
| Tela Bio, INC. | $92.95 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $45.39 | 2023-2025 | Stratafix |
| Boston Scientific Corporation | $35.71 | 2019 | |
| Acella Pharmaceuticals, LLC | $34.68 | 2024 | NP Thyroid 60 |
| Solventum Corporation | $34.07 | 2024-2025 | Prevena |
| W. L. Gore & Associates, INC. | $32.63 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Biocomposites INC | $29.26 | 2019-2021 | |
| Dilon Technologies, INC. | $19.11 | 2025 | Hemoblast Bellows |
| Vertex Pharmaceuticals Incorporated | $18.33 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $17.42 | 2025 | Exparel |
| Biocircuit Technologies INC | $15.46 | 2025 | Nerve Tape |
| Merck Sharp & Dohme LLC | $14.21 | 2020 | |
| Celgene Corporation | $11.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fares Samra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.